Author Details

Balakhonova, T V

Issue Section Title File
Vol 80, No 7 (2008) Editorial Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis
Vol 81, No 6 (2009) Editorial Affection of target organs in hypertensive patients with and without metabolic syndrome
Vol 81, No 9 (2009) Editorial Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment
Vol 83, No 8 (2011) Editorial Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins
Vol 83, No 9 (2011) Editorial Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale
Vol 83, No 12 (2011) Editorial Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications
Vol 84, No 9 (2012) Editorial Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events
Vol 84, No 9 (2012) Editorial Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: Two-year follow-up results
Vol 91, No 9 (2019) Editorial Comparative efficacy and safety of enoxaparin followed by warfarin and rivaroxaban monotherapy in the treatment of venous thrombosis in patients after intracardiac catheter interventions PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies